Clinuvel Board Mulls Change to Group Structure, Potential Nasdaq Listing, ASX Delisting; Shares Dive 9%

MT Newswires Live

Yesterday

Clinuvel Pharmaceuticals (ASX:CUV) said its board is considering a transaction under which the firm would change its group holding structure, seek a listing of its ordinary shares on the Nasdaq Stock Market, and delist from the ASX, according to a Thursday Australian bourse filing.

It is establishing its new headquarters in the US, effective Jan. 1, 2027.

Under a potential scheme of arrangement, a foreign holding company would become the new parent company of the Clinuvel, per the filing. Current shareholders of would receive ordinary shares in the holding company, representing an equivalent proportionate economic interest to their existing stake in Clinuvel. The holding company would then seek to list on the Nasdaq.

The company's shares tumbled 9% in recent trading on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketb.com/news/2662722365"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2662722365\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2662722365?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-27 11:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662722365","market":"sg","top_or_hot":-1,"title":"Clinuvel Board Mulls Change to Group Structure, Potential Nasdaq Listing, ASX Delisting; Shares Dive 9%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/CUV.AU\">Clinuvel Pharmaceuticals</a> (ASX:CUV) said its board is considering a transaction under which the firm would change its group holding structure, seek a listing of its ordinary shares on the Nasdaq Stock Market, and delist from the ASX, according to a Thursday Australian bourse filing.</p><p>It is establishing its new headquarters in the US, effective Jan. 1, 2027.</p><p>Under a potential scheme of arrangement, a foreign holding company would become the new parent company of the Clinuvel, per the filing. Current shareholders of would receive ordinary shares in the holding company, representing an equivalent proportionate economic interest to their existing stake in Clinuvel. The holding company would then seek to list on the Nasdaq.</p><p>The company's shares tumbled 9% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clinuvel Board Mulls Change to Group Structure, Potential Nasdaq Listing, ASX Delisting; Shares Dive 9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClinuvel Board Mulls Change to Group Structure, Potential Nasdaq Listing, ASX Delisting; Shares Dive 9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-27 11:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/CUV.AU\">Clinuvel Pharmaceuticals</a> (ASX:CUV) said its board is considering a transaction under which the firm would change its group holding structure, seek a listing of its ordinary shares on the Nasdaq Stock Market, and delist from the ASX, according to a Thursday Australian bourse filing.</p><p>It is establishing its new headquarters in the US, effective Jan. 1, 2027.</p><p>Under a potential scheme of arrangement, a foreign holding company would become the new parent company of the Clinuvel, per the filing. Current shareholders of would receive ordinary shares in the holding company, representing an equivalent proportionate economic interest to their existing stake in Clinuvel. The holding company would then seek to list on the Nasdaq.</p><p>The company's shares tumbled 9% in recent trading on Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LCLG","symbol_name":"Logan Capital Broad Innovative Growth ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2662722365","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2662722365","pubTimestamp":1787800165,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Clinuvel Pharmaceuticals  said its board is considering a transaction under which the firm would change its group holding structure, seek a listing of its ordinary shares on the Nasdaq Stock Market, and delist from the ASX, according to a Thursday Australian bourse filing.It is establishing its new headquarters in the US, effective Jan. 1, 2027.Under a potential scheme of arrangement, a foreign holding company would become the new parent company of the Clinuvel, per the filing. Current shareholders of would receive ordinary shares in the holding company, representing an equivalent proportionate economic interest to their existing stake in Clinuvel. The holding company would then seek to list on the Nasdaq.The company's shares tumbled 9% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LCLG":"Logan Capital Broad Innovative Growth ETF","CUV.AU":"CLINUVEL PHARMACEUTICALS LTD","BK7067":"生物科技","BK7508":"医药生物股"},"translate_title":"Clinuvel 董事会考虑改变集团结构、可能在纳斯达克上市、澳大利亚证券交易所退市；股价暴跌 9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CUV.AU":1,"NQmain":1.5,"LCLG":1.5},"content_text":"Clinuvel Pharmaceuticals (ASX:CUV) said its board is considering a transaction under which the firm would change its group holding structure, seek a listing of its ordinary shares on the Nasdaq Stock Market, and delist from the ASX, according to a Thursday Australian bourse filing.It is establishing its new headquarters in the US, effective Jan. 1, 2027.Under a potential scheme of arrangement, a foreign holding company would become the new parent company of the Clinuvel, per the filing. Current shareholders of would receive ordinary shares in the holding company, representing an equivalent proportionate economic interest to their existing stake in Clinuvel. The holding company would then seek to list on the Nasdaq.The company's shares tumbled 9% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}